Replies to post #213256 on Biotech Values

[jbog]

RGNX acquires DMTX in all-stock deal—valued at $3.41/sh—a 184% premium to yesterday’s close:

I wonder if the investors who bought in two years ago at $40 are happy today?

[DewDiligence]

RARE offers to acquire DMTX for $5.50/sh cash—a 62% premium to RGNX’s offer in August (#msg-134124483):

https://finance.yahoo.com/news/ultragenyx-proposes-acquire-dimension-therapeutics-123500484.html

DMTX trading is currently halted.

[DewDiligence]

RARE ups DMTX offer to $6/sh cash—RGNX pulls out:

https://finance.yahoo.com/news/regenxbio-responds-notification-superior-proposal-123000678.html

https://finance.yahoo.com/news/dimension-board-determines-ultragenyx-unsolicited-120000716.html

RARE's prior offer had been $5.50/sh in cash (#msg-134695121).